MIF and type 2 diabetes mellitus: Furthermore, increased plasma levels of MIF were identified as a risk factor for increased heart failure in CHD patients with impaired glucose tolerance or type 2 diabetes mellitus (Makino et al., 2010), and were associated with inflammatory marker expression in patients with acute coronary syndrome (ACS) (Muller et al., 2012).